CARsgen Announces Positive Clinical Data for Allogeneic CAR-T Products CT0596 and CT1190B
SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces clinical data for CT0596, an allogeneic BCMA-targeting CAR-T product...
TCT 2025 | Robot-Assisted PCI Enters a New Era: Results of the PANVIS STAR Multicenter Randomized Controlled Trial
SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- The 37th Annual Transcatheter Cardiovascular Therapeutics (TCT2025) symposium was held grandly in San Francisco, USA, attracting widespread attention from the global cardiovascular community. On the morning of...
GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine'
YONGIN, South Korea, Nov. 3, 2025 /PRNewswire/ -- GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been...
AI Semiconductor Innovator DEEPX Recognized by NYSE and WEF
The Leading Player in On-Device AI Is Realizing the Physical AI Era While Drawing Wall Street's Attention NEW YORK, Oct. 31, 2025 /PRNewswire/ -- As AI begins to sustainably generate tangible value, global AI semiconductor innovator DEEPX (CEO...
Pioneering Nuclear Fusion Energy Innovation for Two Decades: Shanghai Electric Empowers Global CRAFT and ITER Projects, Driving a Sustainable Future for Earth
China's Leading High-End Equipment Manufacturer Advances International Cooperation in Nuclear Fusion Energy SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Electric (SEHK: 2727, SSE: 601727) has recently announced several key milestones in the...
Ascletis Selects a Best-in-Class Once-Monthly Subcutaneously Administered Amylin Receptor Agonist, ASC36, for Clinical Development
-In head-to-head non-human primate (NHP) studies, average observed half-life of ASC36 was approximately 15 days, 3 -fold longer than petrelintide, which supports once-monthly subcutaneous (SQ) dosing in humans. -ASC36 demonstrated approximately 91 %...
Xinhua Silk Road: Historic city Quanzhou revitalizes heritage for new opportunities
BEIJING, Oct. 28, 2025 /PRNewswire/ -- Quanzhou, a port city in southeast China's Fujian Province, is renowned for its long history and rich culture. As the city enhances efforts to protect its cultural heritages, it is also taking measures to...
Meet HI the AI Assistant That Could Change How Finance Thinks, Decides and Leads
SYDNEY, Oct. 28, 2025 /PRNewswire/ -- In the high-pressure world of modern finance, decisions are made in seconds - but their impact can last a lifetime. For over 30 years, The Ethics Centre, an independent not-for-profit, has supported individuals...
Amcor's FY25 Sustainability Report showcases progress, leadership and innovation
Pivotal combination with Berry Global unlocks new possibilities ZURICH, Oct. 27, 2025 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, released its fiscal year 2025 (FY25)...
State Grid Xuzhou Power Supply Company: Upgrading the Intelligent Screening Function for Transmission Inspection Images
XUZHOU, China, Oct. 27, 2025 /PRNewswire/ -- Recently, on the 8th tower of the 500kV Baoren 523 Line in Xuzhou, a camera accurately captured a potential safety hazard and completed identification, upload, and alarm notification within 15 minutes....